These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 288469)
41. Lack of neurotoxic effect of diethylpropion in crack-cocaine abusers. Ollo C; Alim TN; Rosse RB; Lindquist T; Green T; Gillis T; Ricci J; Khan M; Deutsch SI Clin Neuropharmacol; 1996 Feb; 19(1):52-8. PubMed ID: 8867517 [TBL] [Abstract][Full Text] [Related]
42. Paranoid-hallucinatory state induced in a depressive patient by methyldopa: a case report. Endo M; Hirai K; Ohara M Psychoneuroendocrinology; 1978 Apr; 3(2):211-5. PubMed ID: 704751 [No Abstract] [Full Text] [Related]
43. Analgesics-antipyretics and etiology and pathogenesis of psychosis. Drtil J Act Nerv Super (Praha); 1971; 13(3):237-8. PubMed ID: 5113851 [No Abstract] [Full Text] [Related]
47. A randomized double-blind placebo-controlled study of the long-term efficacy and safety of diethylpropion in the treatment of obese subjects. Cercato C; Roizenblatt VA; Leança CC; Segal A; Lopes Filho AP; Mancini MC; Halpern A Int J Obes (Lond); 2009 Aug; 33(8):857-65. PubMed ID: 19564877 [TBL] [Abstract][Full Text] [Related]
48. Marihuana and paranoid disperception. Lutz EG J Med Soc N J; 1979 Apr; 76(4):253-9. PubMed ID: 286070 [No Abstract] [Full Text] [Related]
49. Factors affecting the development of spontaneous recurrence of methamphetamine psychosis. Yui K; Ishiguro T; Goto K; Ikemoto S Acta Psychiatr Scand; 1998 Mar; 97(3):220-7. PubMed ID: 9543311 [TBL] [Abstract][Full Text] [Related]
50. [Paranoid psychosis after treatment with the antibiotic ofloxacin]. Hollweg M; Kapfhammer HP Psychiatr Prax; 1996 Sep; 23(5):251. PubMed ID: 8992525 [No Abstract] [Full Text] [Related]
52. Acute hallucinosis due to clonidine. Enoch MD; Hammad GE Curr Med Res Opin; 1977; 4(9):670-1. PubMed ID: 590025 [TBL] [Abstract][Full Text] [Related]
53. Pupillary changes associated with the development of stimulant-induced mania: a case report. Rosse RB; Johri SK; Deutsch SI Clin Neuropharmacol; 1997 Jun; 20(3):270-5. PubMed ID: 9197951 [TBL] [Abstract][Full Text] [Related]
54. [Effect of Elsinore tablets in the treatment of obesity. A controlled clinical trial]. Malchow-Møller A; Larsen S; Hey H; Stokholm KH; Juhl E; Quaade F Ugeskr Laeger; 1980 Jun; 142(23):1496-9. PubMed ID: 6996253 [No Abstract] [Full Text] [Related]
57. Diethylpropion and psychosis. Whitlock FA; Nadorfi MI Med J Aust; 1970 Dec; 2(23):1097. PubMed ID: 5491087 [No Abstract] [Full Text] [Related]
58. The efficacy of the appetite suppressant, diethylpropion, is dependent on both when it is given (day vs. night) and under conditions of high fat dietary restriction. Kalyanasundar B; Solorio J; Perez CI; Hoyo-Vadillo C; Simon SA; Gutierrez R Appetite; 2016 May; 100():152-61. PubMed ID: 26867698 [TBL] [Abstract][Full Text] [Related]
59. Control of weight-gain during pregnancy: use of diethylpropion hydrochloride. Boileau PA Appl Ther; 1968 Nov; 10(11):763-5. PubMed ID: 4883641 [No Abstract] [Full Text] [Related]